Comparison of treatment outcomes in propensity score matched primary lung cancer patients offered anatomical lung resection or oncological treatment following a thoracic high risk multidisciplinary team meeting

Overall survival and disease-free survival were longer in high-risk patients treated with surgery. Similar findings were found per NSCLC stage but LOS was longer while complications and unplanned admissions to critical care were more frequent. Surgery should not be precluded from the treatment of high-risk NSCLC patients, discussed at a HRMDT.